You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 12, December 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Neurological Review
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (88)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Alert me on articles by topic

The Role of Oxidative Stress in Alzheimer Disease

William R. Markesbery, MD

Arch Neurol. 1999;56:1449-1452.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Increasing evidence demonstrates that oxidative stress causes damage to cell function with aging and is involved in a number of age-related disorders including atherosclerosis, arthritis, and neurodegenerative disorders. In the neurodegenerative diseases, oxidative stress has been implicated in amyotrophic lateral sclerosis, Parkinson disease, Huntington disease, and Alzheimer disease (AD). The neurodegenerative disorder receiving the most attention has been AD, in which an increase occurs in oxidation of brain lipids, carbohydrates, proteins, and DNA. Some of the products of oxidation have been found in the major histopathologic alterations in AD: the neurofibrillary tangles (NFTs) and senile plaques (reviewed in Markesbery and Carney1 and Ceballos-Picot2). These oxidative modifications are closely associated with a subtle inflammatory process in the brain in AD.

Oxidative stress refers to a state in which free radicals and their products are in excess of antioxidant defense mechanisms. This imbalance can occur as a . . . [Full Text of this Article]

LIPID PEROXIDATION

PROTEIN OXIDATION

DNA OXIDATION

GLYCO-OXIDATION

ENDOGENOUS ANTIOXIDANTS IN AD

CELL CULTURE AND TRANSGENIC ANIMAL EXPERIMENTS

From the Sanders-Brown Center on Aging, Departments of Pathology and Neurology, University of Kentucky Medical Center, Lexington.


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(12):1538-1539.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of 4-Hydroxy-2-nonenal Modification on {alpha}-Synuclein Aggregation
Qin et al.
J. Biol. Chem. 2007;282:5862-5870.
ABSTRACT | FULL TEXT  

Translational Research on the Way to Effective Therapy for Alzheimer Disease
Rosenberg
Arch Gen Psychiatry 2005;62:1186-1192.
ABSTRACT | FULL TEXT  

Mechanisms of Soluble {beta}-Amyloid Impairment of Endothelial Function
Gentile et al.
J. Biol. Chem. 2004;279:48135-48142.
ABSTRACT | FULL TEXT  

Nutrition- and Virus-Induced Stress Represses the Expression of Manganese Superoxide Dismutase in Vitro
Berger et al.
Exp. Biol. Med. 2004;229:843-849.
ABSTRACT | FULL TEXT  

Alzheimer Disease: Mechanistic Understanding Predicts Novel Therapies
Selkoe
ANN INTERN MED 2004;140:627-638.
FULL TEXT  

Amyloid-{beta} peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway
Lee et al.
J. Cell Biol. 2004;164:123-131.
ABSTRACT | FULL TEXT  

The Role of the Presenilin-1 Homologue Gene sel-12 of Caenorhabditis elegans in Apoptotic Activities
Kitagawa et al.
J. Biol. Chem. 2003;278:12130-12134.
ABSTRACT | FULL TEXT  

Lymphocyte Oxidative DNA Damage and Plasma Antioxidants in Alzheimer Disease
Mecocci et al.
Arch Neurol 2002;59:794-798.
ABSTRACT | FULL TEXT  

Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle
Jaworska-Wilczynska et al.
Neurology 2002;58:438-445.
ABSTRACT | FULL TEXT  

Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease
Adair et al.
Neurology 2001;57:1515-1517.
ABSTRACT | FULL TEXT  

Association of Active Extracellular Signal-Regulated Protein Kinase with Paired Helical Filaments of Inclusion-Body Myositis Muscle Suggests Its Role in Inclusion-Body Myositis Tau Phosphorylation
Wilczynski et al.
Am. J. Pathol. 2000;156:1835-1840.
ABSTRACT | FULL TEXT  

Amyloid-{beta} Peptides Are Cytotoxic to Oligodendrocytes
Xu et al.
J. Neurosci. 2001;21:RC118-RC118.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.